A2M INJECTIONS
What Is Alpha-2-Macroglobulin (A2M) and How Does It Work?
Balance, Resilience & Lasting Wellness
Alpha-2-Macroglobulin (A2M) is a large protein in human blood that traps and neutralizes the enzymes responsible for breaking down cartilage. In a healthy joint it keeps these enzymes in balance. In osteoarthritis, the joint produces far more destructive enzymes than the A2M naturally present can manage, and cartilage gradually wears away. A2M works through a “bait-and-trap” mechanism: a destructive enzyme is drawn to a bait region on the protein, and when it bites, A2M snaps shut around it like a Venus flytrap so the body can clear it. Among the enzymes it captures are matrix metalloproteinases such as MMP-13 and MMP-3, along with the aggrecanases ADAMTS-4 and ADAMTS-5, the main enzymes that dismantle cartilage in osteoarthritis (Tortorella et al., 2004, PMID: 14715656; Wang et al., 2014, PMID: 24578232).
A2M’s protective effect is closely tied to inflammation. In an arthritic joint, inflammatory signals, chiefly the cytokines interleukin-1 beta (Borth et al., 1989, PMID: 2466831) and interleukin-6 (Matsuda et al., 1989, PMID: 2462586), push cells to release more cartilage-degrading enzymes, and the resulting cartilage debris fuels still more inflammation. A2M interrupts this cycle in two ways. It traps a broad range of those destructive enzymes, which is why it is called a master, or broad-spectrum, protease inhibitor. It also binds the inflammatory cytokines that would otherwise keep the cycle going.
A2M at a Glance
What it is:
What it’s used for:
How it works:
The visit:
Results timeline:
At Solutions Regenerative Medicine:
How Is A2M Prepared at Solutions Regenerative Medicine?
A2M is concentrated from a sample of your own blood using the Alpha2Active system, which begins with centrifugation to separate plasma, the same first step in other A2M preparation methods. Because A2M is too dilute in plasma for centrifugation alone to reach a therapeutic dose, a filtration step is needed to concentrate it. Where some A2M systems use a passive filter alone, the Alpha2Active system combines an active, pump-driven membrane filter with a gravity-assisted incline, concentrating A2M up to six times above its normal level. Developed by spine surgeon Dr. Gaetano Scuderi and offered by CAREstream America, the result is an autologous concentrate produced in a single-use, closed, 510(k)-cleared system.
What Conditions Can an A2M Injection Help Address?
A2M injections are used for osteoarthritis and degenerative joint conditions throughout the body, where cartilage breakdown and inflammation drive the problem. Common applications at Solutions Regenerative Medicine include:
- Osteoarthritis and degenerative joint conditions throughout the body, including the knee, hip, shoulder, facet joints of the spine, hands, feet, and elbows. A randomized human trial showed continued improvement in knee pain and function through 12 weeks (Thompson et al., 2024, PMID: 39259950), with animal models showing A2M both calms inflammatory cytokines and inhibits the enzymes that break cartilage down (Wang et al., 2014, PMID: 24578232; Sun et al., 2024, PMID: 39214071)
- Tendon and ligament conditions, including rotator cuff tendinopathy, tennis elbow, and Achilles tendinopathy, where preclinical research found A2M reduces inflammation in the affected tendon (Eliasberg et al., 2025, PMID: 40159684)
- Nerve-root and peripheral nerve pain, such as sciatica, lumbar or cervical radiculopathy, mononeuropathies, and entrapment syndromes like carpal tunnel, where A2M can be delivered into the epidural space or around the affected nerve to target the inflammatory cytokines driving nerve irritation
- Autoimmune joint conditions such as rheumatoid arthritis, driven by the IL-1 and IL-6 inflammation that A2M binds, where A2M may help calm a specific affected joint as part of broader autoimmune care; a preclinical arthritis model found supplemental A2M reduced cartilage and bone damage (2019, PMID: 30609267)
A2M is best suited to early or moderate degeneration. It is a protective therapy that calms inflammation and defends existing cartilage and soft tissue, but it does not regrow tissue already lost or reverse advanced damage. You can also explore Dr. Dunning’s full range of regenerative injection therapies to see how A2M fits with other options.
How Does Dr. Dunning Use A2M in a Treatment Plan?
Dr. Dunning uses A2M in three distinct ways, depending on what your joint needs.
- As part of a diagnostic injection. Dunning sometimes pairs A2M with a diagnostic local-anesthetic injection: the anesthetic confirms which structure is generating your pain, while the A2M delivers an anti-inflammatory therapy in the same visit.
- As an anti-inflammatory and protective injection. Because A2M is drawn from your own blood, it offers an anti-inflammatory option for patients who prefer to avoid or limit corticosteroid (cortisone) injections. Beyond calming current inflammation, A2M’s enzyme-trapping mechanism may also help slow ongoing cartilage breakdown in early to moderate joint disease, an effect cortisone does not provide. Cortisone remains a legitimate tool Dr. Dunning still uses when appropriate.
- As a preparatory step before advanced regenerative treatment. Healing has to move from an inflammatory phase into an active repair phase, a shift driven by immune cells changing from a pro-inflammatory (M1) state to a reparative (M2) state. A joint stuck in chronic inflammation cannot make that shift, so by clearing the inflammatory signals and degradative enzymes, A2M helps the joint progress toward repair and gives a treatment such as PRP, BMAC, or micronized fat the conditions it needs to work. Dr. Dunning describes this as “cleaning house before renovation.”
Dr. Dunning does not combine A2M with another orthobiologic in a single injection, because A2M traps the metalloproteinase enzymes it encounters, and those enzymes are needed in measured amounts for the tissue remodeling a regenerative treatment depends on. Instead, A2M is given as its own visit, with any subsequent regenerative treatment typically scheduled three to four weeks later. By that point the injected A2M has done its anti-inflammatory work, largely cleared the joint, and helped shift the tissue into the proliferative phase where a regenerative treatment can have its strongest effect. Dr. Dunning chooses the exact interval based on each patient’s response and joint condition.
What Can I Expect During and After an A2M Injection?
An A2M injection is completed in a single in-office visit. Your blood is drawn and processed on-site through the Alpha2Active system, and the concentrate is then injected into the affected joint under ultrasound or fluoroscopic guidance.
Early experience varies. In Dr. Dunning’s practice, some patients feel relief within days to a week of the injection, while others have soreness from the injection itself that can last up to seven to ten days. From there, A2M works gradually rather than instantly, with pain and function continuing to improve through six to twelve weeks in clinical trial measurements (Thompson et al., 2024, PMID: 39259950). Longer-term data on A2M beyond twelve weeks remain limited.
In a randomized trial in knee osteoarthritis, A2M delivered pain and function improvements comparable to corticosteroid injection, with A2M continuing to improve across multiple measures through twelve weeks while the corticosteroid arm reached statistical significance on only one measure (Thompson et al., 2024, PMID: 39259950). Standard intra-articular corticosteroid injections typically peak within one to two weeks and provide clinically meaningful relief for about four to six weeks, tapering below the meaningful threshold by three months (Bensa et al., 2024). A2M’s twelve-week trajectory therefore extends well beyond the typical corticosteroid effective window. Dr. Dunning discusses what to expect with you before treatment.
Restoring Function. Improving Quality of Life.
Personalized Care with Regenerative and Naturopathic Medicine.
What Does the Research on A2M Show?
The strongest evidence behind A2M is mechanistic. Joint and tendon pain are driven by a well-characterized inflammatory cascade: cytokines like IL-1β and IL-6, cartilage-degrading enzymes like MMP-13 and the aggrecanases, and a stalled M1-to-M2 macrophage shift that keeps tissue in chronic inflammation instead of moving into repair. A2M is the body’s own broad-spectrum protease inhibitor and a known carrier of those inflammatory cytokines. In vitro work in human chondrocytes has demonstrated that A2M binds IL-1β directly and blocks the downstream NF-κB pathway in a dose-dependent manner, decreasing MMPs and TNF-α and increasing cartilage-protective genes (Sun et al., 2023, PMID: 35451533). A concentrated dose delivers that exact mechanism to the affected joint or tendon.
The clinical evidence is narrower but consistent with the mechanism. The one randomized human trial in knee osteoarthritis showed continued improvement in pain and function through 12 weeks, with results comparable to PRP and corticosteroid injections (Thompson et al., 2024, PMID: 39259950). Preclinical work in animal models of knee osteoarthritis, autoimmune arthritis, and rotator cuff tendinopathy adds further supporting evidence. The published clinical base is still small and longer-term data are limited. Dr. Dunning uses A2M where the mechanism and the patient’s specific condition align.
Why Choose Dr. Dunning at Solutions Regenerative Medicine?
Image guidance is uncommon across regenerative medicine, and fluoroscopy in particular is rarely used outside of providers trained as interventionalists. RMSK certification is also uncommon across the field. Dr. Mareshah Dunning performs every regenerative injection under ultrasound or fluoroscopic (real-time X-ray) guidance. Her fluoroscopy training came from a residency under interventional anesthesiologist and general surgeon Dr. Klee Bethel, and her musculoskeletal ultrasound training was completed under Richard Kates, RMSKS, whose own training came from RMSK pioneers Colin Rigney, DPT, and Wayne Smith, DPT. She is RMSK-certified and serves as faculty lead for the Regenerative Medicine Honors Track at Sonoran University.
Rather than a quick intake and injection, Dr. Dunning identifies your true pain generators first and optimizes your overall health so treatment has the best chance to succeed. She also goes beyond mainstream practice, digging into the literature, mechanistic science, and holistic health to bring patients the best available technology and results. Solutions Regenerative Medicine serves East Valley, Arizona.
Frequently Asked Questions
How is an A2M injection different from PRP, and can they be combined?
PRP and A2M target different phases of joint repair. PRP concentrates platelets and growth factors that drive the proliferative and remodeling phase, while A2M traps the inflammatory cytokines and cartilage-degrading enzymes that keep a joint stuck in chronic inflammation. Both can belong in a treatment plan, but Dr. Dunning gives them at separate visits typically three to four weeks apart: A2M first to clean house and move the joint into the proliferative phase, then PRP to drive new tissue repair. Mixing them in one syringe would have A2M trap the very MMPs that PRP-driven remodeling needs.
How many A2M injections will I need?
This varies by individual, the joint treated, and the severity of degeneration. Some patients are treated with a single injection, while others benefit from a repeat. Notably, one animal study found a single A2M injection performed comparably to three. Dr. Dunning discusses a realistic schedule with you during your consultation.
Is an A2M injection safe?
A2M injections have a strong safety profile because the A2M comes from your own blood, which avoids the risk of rejection or disease transmission associated with donor material. The most common effects are temporary soreness or swelling at the injection site. As with any injection, there is a small risk of infection or tissue damage, both of which Dr. Dunning minimizes through sterile technique, deep anatomic knowledge, and real-time image guidance.
Does insurance cover A2M injections?
A2M injections are not covered by insurance. The A2M product itself will not be reimbursed even with a superbill, though the office visit and injection administration may qualify for partial reimbursement under out-of-network coverage with private insurance. Medicare and Medicaid do not cover A2M. Health Savings Accounts (HSAs) can often be applied toward the cost, and Dr. Dunning’s team reviews all expenses with you before treatment.
What Is the Worst Enemy for Arthritis?
Is A2M Better Than PRP?
What Causes PRP to Fail?
What Are the Downsides of PRP?
What Is Microfat? Understanding Fat-Based Regenerative Injections for Joint Pain
What Are the Side Effects of Micronized Fat Injection?
Solutions Regenerative Medicine
2152 E Broadway Rd.
Tempe, AZ 85282
REAL RELIEF IS A CONSULTATION AWAY
Schedule an Appointment Today!
*All indicated fields must be completed.
Please include non-medical questions and correspondence only.